Therefore, the present study aimed to study SMA disease (type I and II) in pediatric patients in Egypt at the molecular level, and elucidate the possibility of using the molecular assessment of NAIP and SMN genes as a useful tool in predicting the severity of SMA among patients. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.